ROCKET PHARMACEUTICALS, INC. Quarterly Operating Income (Loss) in USD from Q1 2014 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Rocket Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q3 2024.
Rocket Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$69.4M, a 6.11% decline year-over-year.
Rocket Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$274M, a 3.14% decline year-over-year.
Rocket Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$260M, a 15.7% decline from 2022.
Rocket Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$224M, a 34.1% decline from 2021.
Rocket Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$167M, a 24.5% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$274M	-$69.4M	-$4M	-6.11%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	-$270M	-$73.7M	-$4.96M	-7.21%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-06
Q1 2024	-$265M	-$67.4M	-$5.18M	-8.33%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	-$260M	-$63.3M	+$5.8M	+8.4%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-27
Q3 2023	-$265M	-$65.4M	-$6.94M	-11.9%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-07
Q2 2023	-$259M	-$68.8M	-$14.5M	-26.8%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-06
Q1 2023	-$244M	-$62.2M	-$19.6M	-46.1%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-07
Q4 2022	-$224M	-$69.1M	-$24.7M	-55.8%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-27
Q3 2022	-$200M	-$58.5M	-$8.84M	-17.8%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-07
Q2 2022	-$191M	-$54.2M	-$20.2M	-59.2%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-09
Q1 2022	-$171M	-$42.6M	-$3.34M	-8.52%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-05
Q4 2021	-$167M	-$44.3M	+$14.9M	+25.2%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-27
Q3 2021	-$182M	-$49.6M	-$22.3M	-81.3%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-04
Q2 2021	-$160M	-$34M	-$10.5M	-44.5%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-09
Q1 2021	-$149M	-$39.2M	-$15.1M	-62.6%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-06
Q4 2020	-$134M	-$59.2M	-$39.6M	-201%	Oct 1, 2020	Dec 31, 2020	10-K	2021-03-01
Q3 2020	-$94.7M	-$27.4M	-$8.22M	-42.9%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-05
Q2 2020	-$86.5M	-$23.6M	-$5.17M	-28.1%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-09
Q1 2020	-$81.3M	-$24.1M	-$5.18M	-27.3%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-10
Q4 2019	-$76.2M	-$19.6M	+$6.9M	+26%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-01
Q3 2019	-$83M	-$19.2M	-$3.83M	-25%	Jul 1, 2019	Sep 30, 2019	10-K	2021-03-01
Q2 2019	-$79.2M	-$18.4M	-$3.52M	-23.7%	Apr 1, 2019	Jun 30, 2019	10-K	2021-03-01
Q1 2019	-$75.7M	-$18.9M	-$4.54M	-31.5%	Jan 1, 2019	Mar 31, 2019	10-K	2021-03-01
Q4 2018	-$71.2M	-$26.5M	-$19.9M	-299%	Oct 1, 2018	Dec 31, 2018	10-K	2019-03-08
Q3 2018	-$51.3M	-$15.3M	-$8.61M	-128%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-08
Q2 2018	-$42.7M	-$14.9M	-$11.4M	-322%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-08
Q1 2018	-$31.3M	-$14.4M	-$11.5M	-402%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-09
Q4 2017	-$19.8M	-$6.66M	-$28.7M	-130%	Oct 1, 2017	Dec 31, 2017	10-K	2019-03-08
Q3 2017	$8.95M	-$6.73M	+$4M	+37.3%	Jul 1, 2017	Sep 30, 2017	10-K	2019-03-08
Q2 2017	$4.95M	-$3.52M	+$5.26M	+59.9%	Apr 1, 2017	Jun 30, 2017	10-K	2019-03-08
Q1 2017	-$307K	-$2.87M	+$7.27M	+71.7%	Jan 1, 2017	Mar 31, 2017	10-K	2019-03-08
Q4 2016	-$7.57M	$22.1M	+$30.3M		Oct 1, 2016	Dec 31, 2016	10-K	2019-03-08
Q3 2016	-$37.9M	-$10.7M	-$5.29M	-97.2%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-08
Q2 2016	-$32.6M	-$8.78M	-$5.1M	-138%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-03
Q1 2016	-$27.5M	-$10.1M	-$7.09M	-232%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-10
Q4 2015	-$20.4M	-$8.23M	-$6.52M	-381%	Oct 1, 2015	Dec 31, 2015	10-K	2017-03-16
Q3 2015	-$13.9M	-$5.44M	-$3.35M	-161%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-09
Q2 2015	-$10.5M	-$3.68M	-$1.49M	-67.8%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-10
Q1 2015	-$9.04M	-$3.05M	-$1.34M	-78.1%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-11
Q4 2014	-$7.7M	-$1.71M			Oct 1, 2014	Dec 31, 2014	10-K	2016-03-23
Q3 2014		-$2.09M			Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-12
Q2 2014		-$2.19M			Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-07
Q1 2014		-$1.71M			Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.